GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » Research & Development

Medmix AG (XSWX:MEDX) Research & Development : CHF25.4 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medmix AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Medmix AG's Research & Development for the six months ended in Dec. 2024 was CHF11.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was CHF25.4 Mil.

Medmix AG Research & Development Historical Data

The historical data trend for Medmix AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medmix AG Research & Development Chart

Medmix AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial 20.20 23.00 23.60 25.70 25.40

Medmix AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.30 12.90 12.80 13.70 11.70

Medmix AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF25.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medmix AG  (XSWX:MEDX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Medmix AG Research & Development Related Terms

Thank you for viewing the detailed overview of Medmix AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Medmix AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » Research & Development
Comparable Companies
XSWX:PMN XSWX:MTG XSWX:RIEN XSWX:BYS XSWX:KOMN XSWX:MIKN XSWX:STGN XSWX:FTON XSWX:KLIN XSWX:STRN XTER:SIE XPAR:SU ETN GEV PH OSTO:ATCO A ITW TSE:7011 XTER:ENR EMR
Traded in Other Exchanges
MEDXz:UK
Address
Neuhofstrasse 20, Baar, CHE, 6340
Website
https://www.medmix.swiss
Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery, and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of its revenue is from the Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways, and aerospace), electronics assembly, infrastructure, and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas, and Asia-Pacific.

Medmix AG Headlines